4//SEC Filing
CytomX Therapeutics, Inc. 4
Accession 0001140361-15-037813
$CTMXCIK 0001501989operating
Filed
Oct 15, 8:00 PM ET
Accepted
Oct 16, 10:19 AM ET
Size
9.4 KB
Accession
0001140361-15-037813
Insider Transaction Report
Form 4
LADD CYNTHIA J
Senior VP and General Counsel
Transactions
- Award
Employee Stock Option (right to buy)
2015-07-21+246,043→ 246,043 totalExercise: $6.61Exp: 2025-07-20→ Common Stock (246,043 underlying) - Purchase
Common Stock
2015-10-14$12.00/sh+3,000$36,000→ 3,000 total - Award
Employee Stock Option (right to buy)
2015-08-26+27,393→ 27,393 totalExercise: $6.61Exp: 2025-08-25→ Common Stock (27,393 underlying)
Footnotes (2)
- [F1]This option vests 25% on June 15, 2016, and the remaining 75% vests in 36 substantially equal monthly installments thereafter, with each additional installment vesting on the last day the month, except the final installment, which shall vest on June 15, 2019.
- [F2]This option vests in 48 substantially equal monthly installments starting on August 28, 2015, with each additional installment vesting on the last day of the month.
Documents
Issuer
CytomX Therapeutics, Inc.
CIK 0001501989
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001501989
Filing Metadata
- Form type
- 4
- Filed
- Oct 15, 8:00 PM ET
- Accepted
- Oct 16, 10:19 AM ET
- Size
- 9.4 KB